INTRA-CELLULAR THERAPIES INC

CUSIP: 46116X101 Class: Common Stock

Skandinaviska Enskilda Banken AB (publ)'s Holding History (CIK: 0001534653)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 35,000 Value ($000) $4,618 Avg Close Range
Q4 2024
Shares 278,711 Value ($000) $23,268 Avg Close Range
Q3 2024
Shares 278,711 Value ($000) $20,392 Avg Close Range
Q2 2024
Shares 259,121 Value ($000) $17,742 Avg Close Range
Q1 2024
Shares 130,213 Value ($000) $8,998 Avg Close Range
Q4 2023
Shares 290,931 Value ($000) $20,825 Avg Close Range
Q3 2023
Shares 404,112 Value ($000) $21 Avg Close Range
Q2 2023
Shares 404,112 Value ($000) $26 Avg Close Range
Q1 2023
Shares 268,363 Value ($000) $15 Avg Close Range
Q4 2022
Shares 373,076 Value ($000) $20 Avg Close Range
Q3 2022
Shares 383,565 Value ($000) $17,836 Avg Close Range
Q2 2022
Shares 383,565 Value ($000) $21,882 Avg Close Range
Q1 2022
Shares 391,937 Value ($000) $23,971 Avg Close Range
Q4 2021
Shares 396,279 Value ($000) $20,666 Avg Close Range
Q3 2021
Shares 292,463 Value ($000) $10,885 Avg Close Range
Q2 2021
Shares 292,463 Value ($000) $11,938 Avg Close Range
Q1 2021
Shares 25,722 Value ($000) $874 Avg Close Range